Carlos Parra-Herran

No ORCID on file · 6 papers in corpus · active 2016-2025

Study types

  • article 3
  • other 3

Condition tags

  • endometriosis 4
  • adenomyosis 2
  • mesh:D004715 1
other 2025
NPJ precision oncology ·doi:10.1038/s41698-025-00849-1

Long interspersed element 1 (LINE-1) retrotransposons are repetitive sequences that can move within the genome by an autonomous mechanism. To limit their mutagenic potential, benign cells restrict LINE-1 expression through molecular mechani…

other 2021
The American journal of surgical pathology ·doi:10.1097/PAS.0000000000001643

Mullerian adenosarcoma is a biphasic neoplasm composed of benign or atypical Müllerian epithelium and a malignant mesenchymal component that is usually, but not always, of low grade. Focal architectural or cytologic atypia of the epithelial…

article 2020
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists ·doi:10.1097/pgp.0000000000000673

Ovarian carcinoma with a somatically derived yolk sac tumor component is a phenomenon known to mostly occur in postmenopausal women. Herein, we report an ovarian endometriosis-associated somatic yolk sac tumor arising in the background of a…

other 2019
The American journal of surgical pathology ·doi:10.1097/PAS.0000000000001328

The PROMISE diagnostic algorithm, which uses p53, mismatch repair (MMR) protein immunohistochemistry, and DNA polymerase ε (POLE) exonuclease domain mutation testing, is a reliable surrogate of the molecular group in endometrial carcinoma. …

article 2016
American journal of clinical pathology ·doi:10.1093/ajcp/aqw021

BACKGROUND: Distinguishing myometrial invasion from adenomyosis involvement is important for staging of endometrial endometrioid adenocarcinoma. We aimed to compare CD10, which has limited value in this scenario, with interferon-induced tra…

article 2016
Pathology, research and practice ·doi:10.1016/j.prp.2016.06.007